Lucas Ward
Stock Analyst at Ascendiant Capital
(n/a)
# 4,780
Out of 4,801 analysts
14
Total ratings
n/a
Success rate
-52.39%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| LIQT LiqTech International | Reiterates: Buy | $3.2 → $3.4 | $1.58 | +115.19% | 4 | Apr 7, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $2.79 | +402.69% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $8.97 | +5,262.32% | 3 | Nov 27, 2024 | |
| VVOS Vivos Therapeutics | Reiterates: Buy | $6.6 | $2.52 | +161.90% | 2 | Nov 20, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $4.80 | +56,150.00% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $144 | $1.80 | +7,907.12% | 1 | Oct 2, 2023 |
LiqTech International
Apr 7, 2025
Reiterates: Buy
Price Target: $3.2 → $3.4
Current: $1.58
Upside: +115.19%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $2.79
Upside: +402.69%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $8.97
Upside: +5,262.32%
Vivos Therapeutics
Nov 20, 2024
Reiterates: Buy
Price Target: $6.6
Current: $2.52
Upside: +161.90%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $4.80
Upside: +56,150.00%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $144
Current: $1.80
Upside: +7,907.12%